68 related articles for article (PubMed ID: 2187485)
21. [A serine proteinase from Thermoactinomyces vulgaris, strain INMI-4a].
Stepanov VM; Rudenskaia GN; Nesterova NG; Kupriianova TI; Khokhlova IuM
Biokhimiia; 1980 Oct; 45(10):1871-80. PubMed ID: 7016198
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct.
Chavan SJ; Bornmann WG; Flexner C; Prochaska HJ
Arch Biochem Biophys; 1995 Dec; 324(1):143-52. PubMed ID: 7503549
[TBL] [Abstract][Full Text] [Related]
23. Purification and partial characterization of an acid proteinase from Dirofilaria immitis.
Sato K; Nagai Y; Suzuki M
Mol Biochem Parasitol; 1993 Apr; 58(2):293-9. PubMed ID: 8479453
[TBL] [Abstract][Full Text] [Related]
24. Expression of an autoprocessing CAT-HIV-1 proteinase fusion protein: purification to homogeneity of the release 99 residue proteinase.
Montgomery DS; Singh OM; Gray NM; Dykes CW; Weir MP; Hobden AN
Biochem Biophys Res Commun; 1991 Mar; 175(3):784-94. PubMed ID: 2025253
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the pH-dependencies of the association and dissociation kinetics of HIV-1 protease inhibitors.
Gossas T; Danielson UH
J Mol Recognit; 2003; 16(4):203-12. PubMed ID: 12898670
[TBL] [Abstract][Full Text] [Related]
26. Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor.
Copeland TD; Wondrak EM; Tozser J; Roberts MM; Oroszlan S
Biochem Biophys Res Commun; 1990 May; 169(1):310-4. PubMed ID: 2190554
[TBL] [Abstract][Full Text] [Related]
27. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
[TBL] [Abstract][Full Text] [Related]
28. Reexamination of the activation of yeast proteinase B at pH 5: loss of inhibition effect of proteinase B inhibitors.
Magni G; Drewniak M; Santarelli I; Huang CY
Biochem Int; 1986 Apr; 12(4):557-65. PubMed ID: 3521610
[TBL] [Abstract][Full Text] [Related]
29. Purification of HIV-1 wild-type protease and characterization of proteolytically inactive HIV-1 protease mutants by pepstatin A affinity chromatography.
Wondrak EM; Louis JM; Mora PT; Oroszlan S
FEBS Lett; 1991 Mar; 280(2):347-50. PubMed ID: 2013336
[TBL] [Abstract][Full Text] [Related]
30. Purification and characterization of a recombinant alpha-N-acetylgalactosaminidase from Clostridium perfringens.
Hsieh HY; Calcutt MJ; Chapman LF; Mitra M; Smith DS
Protein Expr Purif; 2003 Dec; 32(2):309-16. PubMed ID: 14965778
[TBL] [Abstract][Full Text] [Related]
31. Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.
Erickson J; Neidhart DJ; VanDrie J; Kempf DJ; Wang XC; Norbeck DW; Plattner JJ; Rittenhouse JW; Turon M; Wideburg N
Science; 1990 Aug; 249(4968):527-33. PubMed ID: 2200122
[TBL] [Abstract][Full Text] [Related]
32. Rational design of peptide-based HIV proteinase inhibitors.
Roberts NA; Martin JA; Kinchington D; Broadhurst AV; Craig JC; Duncan IB; Galpin SA; Handa BK; Kay J; Kröhn A
Science; 1990 Apr; 248(4953):358-61. PubMed ID: 2183354
[TBL] [Abstract][Full Text] [Related]
33. An aspartic proteinase from Fusarium moniliforme. Purification and general properties.
Kołaczkowska MK; Wieczorek M; Polanowski A
Eur J Biochem; 1983 May; 132(3):557-61. PubMed ID: 6343078
[TBL] [Abstract][Full Text] [Related]
34. Colorimetric assay of HIV-1 proteinase suitable for high-capacity screening.
Billich A; Winkler G
Pept Res; 1990; 3(6):274-6. PubMed ID: 2134071
[TBL] [Abstract][Full Text] [Related]
35. Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus.
Grobelny D; Wondrak EM; Galardy RE; Oroszlan S
Biochem Biophys Res Commun; 1990 Jun; 169(3):1111-6. PubMed ID: 2114105
[TBL] [Abstract][Full Text] [Related]
36. Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases.
Wallin M; Deinum J; Goobar L; Danielson UH
J Gen Virol; 1990 Sep; 71 ( Pt 9)():1985-91. PubMed ID: 2212989
[TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease.
Darke PL; Leu CT; Davis LJ; Heimbach JC; Diehl RE; Hill WS; Dixon RA; Sigal IS
J Biol Chem; 1989 Feb; 264(4):2307-12. PubMed ID: 2644259
[TBL] [Abstract][Full Text] [Related]
38. Purification and partial characterization of rat brain acid proteinase (isorenin).
Hackenthal E; Hackenthal R; Hilgenfeldt U
Biochim Biophys Acta; 1978 Feb; 522(2):561-73. PubMed ID: 23850
[TBL] [Abstract][Full Text] [Related]
39. Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution.
Fitzgerald PM; McKeever BM; VanMiddlesworth JF; Springer JP; Heimbach JC; Leu CT; Herber WK; Dixon RA; Darke PL
J Biol Chem; 1990 Aug; 265(24):14209-19. PubMed ID: 2201682
[TBL] [Abstract][Full Text] [Related]
40. Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides.
Kräusslich HG; Ingraham RH; Skoog MT; Wimmer E; Pallai PV; Carter CA
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):807-11. PubMed ID: 2644644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
